[Mechanism of action and adverse effect of antihypertensive agents and their countermeasures].
Hiwada
K
K
D000317:Adrenergic alpha-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000319:Adrenergic beta-Antagonists / Q000009:adverse effects / Q000494:pharmacology; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000494:pharmacology*; D001581:Benzothiadiazines; D004232:Diuretics; D004347:Drug Interactions; D006801:Humans; D049993:Sodium Chloride Symporter Inhibitors / Q000009:adverse effects / Q000494:pharmacology; D013565:Sympatholytics / Q000009:adverse effects / Q000494:pharmacology; D014665:Vasodilator Agents / Q000009:adverse effects / Q000494:pharmacology
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D001581:Benzothiadiazines; D004232:Diuretics; D049993:Sodium Chloride Symporter Inhibitors; D013565:Sympatholytics; D014665:Vasodilator Agents